Journal Article Summary
The article examines fertility-sparing treatments for atypical endometrial hyperplasia (AEH) and endometrial cancer, which are significant health concerns for women, especially those of childbearing age. Endometrial cancer is increasingly common, particularly in high-income countries, and AEH can precede this type of cancer. Many women are delaying childbirth and may want to preserve their fertility while managing these conditions, making it essential to explore effective treatment options that do not require a hysterectomy.
The researchers analyzed 12 studies involving 904 women, including both randomized controlled trials and non-randomized studies. They compared various fertility-sparing treatments, such as oral progestin, the levonorgestrel intrauterine system (IUS), metformin, and surgical options. The findings indicated that while adding metformin to progestin might slightly improve the complete response rate (absence of detectable cancer), it had little effect on live birth rates or the need for surgery. The levonorgestrel IUS showed similar effectiveness to oral progestin but with potentially fewer side effects, such as weight gain.
However, the evidence has limitations, including a high risk of bias in the studies and a lack of comprehensive data on key outcomes like overall survival and quality of life. Patients should be aware that the current findings are based on low-certainty evidence, and further research is needed to clarify the best treatment options. It is crucial for women facing these conditions to discuss their individual situations and treatment preferences with healthcare professionals to make informed decisions about their care and fertility preservation.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Fernandez-Montoli Maria-Eulalia, Sabadell Jordi, Contreras Perez Nayanar Adela, Verdaguer Menéndez-Arango Paula, Julia Torres Carla, Lleberia Judith. Fertility‐sparing treatment for atypical endometrial hyperplasia and endometrial cancer. The Cochrane Database of Systematic Reviews 2025. DOI: 10.1002/14651858.CD013111.pub2. PMID: 40626388. PMCID: PMC12235751.
Featured Pill Pals Product
My Way (Levonorgestrel) 1.5 mg Tablet - Generic For Plan B and Morning After Pill --- Lupin Pharma --- Over The Counter
My Way (Levonorgestrel) 1.5 mg Tablet – Generic For Plan B and Morning After Pill — Lupin Pharma — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
